Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ana Luiza Barbosa dos Santos"'
Autor:
Rafael Rodrigues Silva, Rafael M Mariante, Andrea Alice Silva, Ana Luiza Barbosa dos Santos, Ester Roffê, Helton Santiago, Ricardo Tostes Gazzinelli, Joseli Lannes-Vieira
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0118600 (2015)
The inflammatory cytokine interferon-gamma (IFNγ) is crucial for immunity against intracellular pathogens such as the protozoan parasite Trypanosoma cruzi, the causative agent of Chagas disease (CD). IFNγ is a pleiotropic cytokine which regulates a
Externí odkaz:
https://doaj.org/article/2d4ae38ec372415c953ff79c37a105eb
Autor:
Luana Isaias, Suzane Bertoni, Ana Luiza Barbosa dos Santos, Esperança da Luz Tinoco Ribeiro, Lívia Borsato, Hye Chung Kang
Publikováno v:
Jornal Brasileiro de Patologia e Medicina Laboratorial, Vol 49, Iss 4, Pp 264-265 (2013)
The sickle cell nephropathy is described as a homozygous sickle cell disease. However, there is no consensus as to the heterozygotes, thus other investigations are required to provide further information on this topic. This study aimed at determining
Externí odkaz:
https://doaj.org/article/98f7a1284f5f4feb92fbe07e0b61c0e5
Autor:
Hye Chung Kang, Suzane Bertoni, Ana Luiza Barbosa dos Santos, Luana Isaias, Lívia Borsato, Esperança da Luz Tinoco Ribeiro
Publikováno v:
Jornal Brasileiro de Patologia e Medicina Laboratorial, Vol 49, Iss 4, Pp 264-265 (2013)
Jornal Brasileiro de Patologia e Medicina Laboratorial v.49 n.4 2013
Jornal Brasileiro de Patologia e Medicina Laboratorial
Sociedade Brasileira de Patologia (SBP)
instacron:SBP
Jornal Brasileiro de Patologia e Medicina Laboratorial, Volume: 49, Issue: 4, Pages: 264-265, Published: AUG 2013
Jornal Brasileiro de Patologia e Medicina Laboratorial v.49 n.4 2013
Jornal Brasileiro de Patologia e Medicina Laboratorial
Sociedade Brasileira de Patologia (SBP)
instacron:SBP
Jornal Brasileiro de Patologia e Medicina Laboratorial, Volume: 49, Issue: 4, Pages: 264-265, Published: AUG 2013
The sickle cell nephropathy is described as a homozygous sickle cell disease. However, there is no consensus as to the heterozygotes, thus other investigations are required to provide further information on this topic. This study aimed at determining